Analysis of the oligomeric state and transactivation potential of TAp73α

Cell Death and Differentiation

Volumn 20, Issue 8, 2013, Pages 1008-1016

  Luh, L M ^a   Kehrloesser, S ^a   Deutsch, G B ^a   Gebel, J ^a   Coutandin, D ^a   Schafer B ^a   Agostini, M ^b   Melino, G ^b,c,d   Dotsch V ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

p53 family; p63; p73; Tetramerization; Transcriptional activity

Indexed keywords

AMINO ACID; PROTEIN; PROTEIN P53; PROTEIN P63; PROTEIN P73; TAP63 ALPHA PROTEIN; TETRAMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CONFORMATION; DIMERIZATION; DNA BINDING; GEL PERMEATION CHROMATOGRAPHY; MOUSE; MUTATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEOTIDE SEQUENCE; OOCYTE; PRIORITY JOURNAL; PROMOTER REGION; RETICULOCYTE LYSATE; TRANSACTIVATION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; DNA-BINDING PROTEINS; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN ISOFORMS; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEINS;

EID: 84880298343     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.23     Document Type: Article

References (49)

1. Yang A, Kaghad M, Caput D, McKeon F. On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet 2002; 18: 90-95.
2. Coutandin D, Der Ou H, Lohr F, Dotsch V. Tracing the protectors path from the germ line to the genome. Proc Natl Acad Sci USA 2010; 107: 15318-15325.
3. Levine AJ, Tomasini R, McKeon FD, Mak TW, Melino G. The p53 family: guardians of maternal reproduction. Nat Rev Mol Cell Biol 2011; 12: 259-265.
4. Ollmann M, Young LM, Di Como CJ, Karim F, Belvin M, Robertson S et al. Drosophila p53 is a structural and functional homolog of the tumor suppressor p53. Cell 2000; 101: 91-101.
5. Brodsky MH, Nordstrom W, Tsang G, Kwan E, Rubin GM, Abrams JM. Drosophila p53 binds a damage response element at the reaper locus. Cell 2000; 101: 103-113.
6. Pearson BJ, Sanchez Alvarado A. A planarian p53 homolog regulates proliferation and self-renewal in adult stem cell lineages. Development 2010; 137: 213-221.
7. Derry WB, Putzke AP, Rothman JH. Caenorhabditis elegans p53: role in apoptosis, meiosis, and stress resistance. Science 2001; 294: 591-595.
8. Ou HD, Lohr F, Vogel V, Mantele W, Dotsch V. Structural evolution of C-terminal domains in the p53 family. EMBO J 2007; 26: 3463-3473.
9. Schumacher B, Hofmann K, Boulton S, Gartner A. The C. elegans homolog of the p53 tumor suppressor is required for DNA damage-induced apoptosis. Curr Biol 2001; 11: 1722-1727.
10. Derry WB, Bierings R, van Iersel M, Satkunendran T, Reinke V, Rothman JH. Regulation of developmental rate and germ cell proliferation in Caenorhabditis elegans by the p53 gene network. Cell Death Differ 2007; 14: 662-670.
11. Suh EK, Yang A, Kettenbach A, Bamberger C, Michaelis AH, Zhu Z et al. p63 protects the female germ line during meiotic arrest. Nature 2006; 444: 624-628.
12. Kerr JB, Hutt KJ, Michalak EM, Cook M, Vandenberg CJ, Liew SH et al. DNA damageinduced primordial follicle oocyte apoptosis and loss of fertility require tap63-mediated induction of Puma and Noxa. Mol Cell 2012; 48: 343-352.
13. Deutsch GB, Zielonka EM, Coutandin D, Weber TA, Schafer B, Hannewald J et al. DNA damage in oocytes induces a switch of the quality control factor TAp63alpha from dimer to tetramer. Cell 2011; 144: 566-576.
14. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominantnegative activities. Mol Cell 1998; 2: 305-316.
15. Melino G. p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53. Cell Death Differ 2011; 18: 1487-1499.
16. Beyer U, Moll-Rocek J, Moll UM, Dobbelstein M. Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes. Proc Natl Acad Sci USA 2011; 108: 3624-3629.
17. Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, Cheung CC et al. TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev 2008; 22: 2677-2691.
18. Rufini A, Agostini M, Grespi F, Tomasini R, Sayan BS, Niklison-Chirou MV et al. p73 in Cancer. Genes Cancer 2011; 2: 491-502.
19. De Laurenzi V, Costanzo A, Barcaroli D, Terrinoni A, Falco M, Annicchiarico-Petruzzelli M et al. Two new p73 splice variants, g and d, with different transcriptional activity. J Exp Med 1998; 188: 1763-1768.
20. De Laurenzi V, Catani M, Terrinoni A, Corazzari M, Melino G, Costanzo A et al. Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants epsilon and zeta. Cell Death Differ 1999; 6: 389-390.
21. Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, Pearl M et al. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J Exp Med 2002; 196: 765-780.
22. Putzer BM, Tuve S, Tannapfel A, Stiewe T. Increased DeltaN-p73 expression in tumors by upregulation of the E2F1-regulated, TA-promoter-derived DeltaN'-p73 transcript. Cell Death Differ 2003; 10: 612-614.
23. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 2000; 404: 99-103.
24. Conforti F, Sayan AE, Sreekumar R, Sayan BS. Regulation of p73 activity by posttranslational modifications. Cell Death Dis 2012; 3: e285.
25. Straub WE, Weber TA, Schafer B, Candi E, Durst F, Ou HD et al. The C-terminus of p63 contains multiple regulatory elements with different functions. Cell Death Dis 2010; 1: e5.
26. Khoury MP, Bourdon JC. p53 isoforms: an intracellular microprocessor? Genes Cancer 2011; 2: 453-465.
27. Serber Z, Lai HC, Yang A, Ou HD, Sigal MS, Kelly AE et al. A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism. Mol Cell Biol 2002; 22: 8601-8611.
28. Coutandin D, Löhr F, Niesen F, Ikeya T, Weber T, Schäfer B et al. Conformational stability and activity of p73 require a second helix in the tetramerization domain. Cell Death Differ 2009; 16: 1582-1589.
29. Joerger AC, Rajagopalan S, Natan E, Veprintsev DB, Robinson CV, Fersht AR. Structural evolution of p53, p63, and p73: implication for heterotetramer formation. Proc Natl Acad Sci USA 2009; 106: 17705-17710.
30. Natan E, Joerger AC. Structure and kinetic stability of the p63 tetramerization domain. J Mol Biol 2012; 415: 503-513.
31. Jeffrey PD, Gorina S, Pavletich NP. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science 1995; 267: 1498-1502.
32. Davison TS, Nie X, Ma W, Lin Y, Kay C, Benchimol S et al. Structure and functionality of a designed p53 dimer. J Mol Biol 2001; 307: 605-617.
33. Rocco JW, Leong CO, Kuperwasser N, DeYoung MP, Ellisen LW. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 2006; 9: 45-56.
34. Dotsch V, Bernassola F, Coutandin D, Candi E, Melino G. p63 and p73, the ancestors of p53. Cold Spring Harb Perspect Biol 2010; 2: a004887.
35. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999; 398: 714-718.
36. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999; 398: 708-713.
37. Senoo M, Pinto F, Crum CP, McKeon F. p63 is essential for the proliferative potential of stem cells in stratified epithelia. Cell 2007; 129: 523-536.
38. Hu W, Feng Z, Teresky AK, Levine AJ. p53 regulates maternal reproduction through LIF. Nature 2007; 450: 721-724.
39. Flores ER, Tsai KY, Crowley D, Sengupta S, Yang A, McKeon F et al. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 2002; 416: 560-564.
40. Graziano V, De Laurenzi V. Role of p63 in cancer development. Biochim Biophys Acta 2011; 1816: 57-66.
41. Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE et al. AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA 2000; 97: 5462-5467.
42. Maas AM, Bretz AC, Mack E, Stiewe T. Targeting p73 in cancer. Cancer Lett 2011, doi:10.1016/j.canlet.2011.07.030.
43. Wade M, Wang YV, Wahl GM. The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol 2010; 20: 299-309.
44. Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell 2009; 137: 413-431.
45. Sayan BS, Yang AL, Conforti F, Tucci P, Piro MC, Browne GJ et al. Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2. Proc Natl Acad Sci USA 2010; 107: 12877-12882.
46. Mantovani F, Piazza S, Gostissa M, Strano S, Zacchi P, Mantovani R et al. Pin1 links the activities of c-Abl and p300 in regulating p73 function. Mol Cell 2004; 14: 625-636.
47. Agami R, Blandino G, Oren M, Shaul Y. Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis. Nature 1999; 399: 809-813.
48. Yuan ZM, Shioya H, Ishiko T, Sun X, Gu J, Huang YY et al. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature 1999; 399: 814-817.
49. Lapi E, Di Agostino S, Donzelli S, Gal H, Domany E, Rechavi G et al. PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. Mol Cell 2008; 32: 803-814.